How Much Did Merck Know?
“Merck had notice through adverse reports starting in 1996”, Boles attorney recently stated in an interview. Since then, the company has had “thousands of reports” regarding jawbone-tissue loss, he elaborated. A major issue that is being raised in the Fosamax lawsuit is over whether Fosamax can cause ONJ if it’s taken for a period of less than three years. The judge presiding over the case has put off a decision regarding what expert testimony he will allow on the subject for no; the issue isn’t relevant to the Boles’ case since she took the drug for longer than three years. The federal-court Fosamax trials are currently slated for December and January. An additional state court trial is scheduled later this year in Alabama.
